Medprin Regenerative Medical Technologies Inc. (301033)
XSHE XSHE Primary Summary
301033 Chart
People also search for
Medprin Regenerative Medical Technologies Inc. (301033) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Medprin Regenerative Medical Technologies Inc. ever had a stock split?
Medprin Regenerative Medical Technologies Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Jianhua Wang CEO | XSHE Exchange | CNE100004NB8 ISIN |
| CN Country | 447 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Medprin Regenerative Medical Technologies Co., Ltd., founded in 2008 and headquartered in Guangzhou, China, is a pioneer in the field of regenerative medicine. Specializing in the research, development, manufacture, and sale of implantable medical devices, Medprin has positioned itself as a key player in the global healthcare sector. The company is dedicated to advancing the field of regenerative medicine through innovative solutions, offering a range of products designed to improve patient outcomes in various medical specialties. With a strong international presence, Medprin serves patients across the globe, contributing significantly to the advancement of medical treatments and technologies.
Products and Services
- Dura Membrane Patches:
These patches are designed for neurosurgical use, providing a solution for dural repair and reconstruction. Dura membrane patches help to protect the brain and spinal cord after surgery or injury.
- Regenerated Oxidized Cellulose:
A bioresorbable material used for hemostasis, aiding in controlling bleeding during surgical procedures. This product highlights Medprin’s capability in utilizing regenerative materials for acute medical needs.
- Craniomaxillofacial Repair Systems:
These systems are used in the reconstruction of facial and cranial defects, offering patient-specific implants and devices to restore functionality and aesthetics in patients who have suffered trauma or require reconstructive surgery.
- ReDura, NeoDura, Recranio, and StypCel:
These products are specially designed for neurosurgery applications, providing advanced solutions for cranial reconstruction, dural repair, and bleeding control. Each product serves a specific purpose in the neurosurgical field, from sealing the dura mater to providing a scaffold for tissue regeneration.
- 3D Bioprinting Applications:
Medprin’s involvement in 3D bioprinting signifies its commitment to cutting-edge technology in regenerative medicine. This technology allows for the creation of three-dimensional, cell-laden scaffolds, which can be used in various medical disciplines, promoting tissue regeneration and repair.
